EN
HI

PANACEA BIOTEC Share price

PANACEABIO

HealthcareMid

538

24.35 (4.74%)
NSE
BSE
Last updated on 13 May, 2025 | 11:39 IST
BUYSELL
Today's High

518.00

Today's Low

539.30

52 Week Low

581.90

52 Week High

581.90

The current prices are delayed, login to your account for live prices

Panacea Biotec Chart

PANACEA BIOTEC Share Key Metrics

Volume
3.50 L
Market Cap
3146.14 CR
LTQ@LTP
1@538.00
ATP
535.53
Var Margin
2793
Circuit Range
488-539.3
Delivery %
62.16
Value
18.72 CR
ASM/GSM
No
Market Lot
1

PANACEA BIOTEC Futures & Options

Data Not Found

PANACEA BIOTEC Corporate Actions

DateAgenda
2025-02-14Quarterly Results
DateEvent TypeAgenda
2025-02-14Board MeetingQuarterly Results

PANACEA BIOTEC News

Panacea Biotec shares rally 5% as co gets UNICEF supply order worth Rs 127 crore

Dec 26 2024 09:56:53

Panacea Biotec shares in focus as co gets UNICEF supply order worth Rs 127 crore

Dec 26 2024 09:31:53
Read More

About PANACEA BIOTEC AboutThe

NSE : 4055  
BSE : 531349  
ISIN : INE922B01023  

Panacea Biotec Ltd. was incorporated as a private limited company in the name and style of Panacea Drugs Private Ltd. on 2nd February 1984. Subsequently the Company became deemed Public limited Company u/s 43A(1 A) of the Companies Act 1956 w.e.f. 30.6.93. The shareholders of the Company in Extra Ordinary General Meeting passed a special resolution on 26.7.93 for deleting the Registration Clause from Articles of Association of the Company u/s 3(1) (iii) of the Companies Act 1956 and as such Company became full fledge public limited Company within the meaning of Section 3 (1) iv) of the Companies Act. Thereafterer the name of the Company hanged to Panacea Biotec Limited on 7th September 1993.The Company has been promoted by Mr. Sosh Kumar Jain who is a pharmacist having about 40 years of experience in the pharmaceutical industry.The Company started its operations in the year 1985 by identifying and importing a group of life saving drugs which were not available in the country for acute diseases like cancer haemophilia cardiac diseases infertility etc. These drugs were imported at an economical price andmade available through a distribution network of stockists all over the country. Having made a significant presence in the markat and after understanding the scope of the product and the latest trend in the medical field the Company made plans to set up its own manufacturing unit in 1989 and thereafter established a marketing team with an already existing distribution network for promotion of ethicalformulations.The promotors of the Company also happened to be the artners in another group company - Radicura Pharma engaged in he line of business of vaccines. Having established its marketing strength in both the group companies i.e. Vaccine Division as well as Pharma marketing the Company decided to make a single entity by merging both the unitsin the year 1992. The company is now utilising the strength of the products and marketing team of both the unit for better performance in the coming years. The Company continue to manufacture the Vaccines under Radicura Pharma with the after now functioning as a division of the Company.The Company started its Export promotion in 1991-92 when product registration in different countries was initiated. During 1993-94 the Comapny exported products worth Rs. 1.00 Crore.Presently the Company is engaged in 4 product lines of Pharmaceuticals. These are :- a) Vaccines b) Biologicals c) formulations d) Natural ProductsThe ethical formulations being promoted is on an all India basis. The Company has a significant presence in different therapeutic Groups. The company has a well established marketing network with dealers spread all over the country. The Company now proposes to expand the capacity of Vaccines Division along with an expansion in the capacities of capsules and suspensions.The company has achieved consistent improvement in rating terms of retail chemist sales out of top 200 Companies in India (Source: ORG Retail Sales Rating) out of companies promoting products ethically.Year March 1993 March 1994Rating 187 153Out of 200 200

PANACEA BIOTEC Management

NamePosition
Dr. Rajesh Jain Chairman & Managing Director
Mr. Sandeep Jain Joint Managing Director
Mr. Ankesh Jain Whole Time Director
Mrs. Ambika Sharma Non Executive Director
Mr. N N Khamitkar Non Executive Director
Read More

PANACEA BIOTEC FAQs

PANACEA BIOTEC शेयर का खरीद मूल्य 121.5 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

PANACEA BIOTEC शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

PANACEA BIOTEC शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

PANACEA BIOTEC शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 9.67 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

PANACEA BIOTEC शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.68 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

PANACEA BIOTEC का मार्केट कैप 3146.14 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

PANACEA BIOTEC शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 581.90 और 112.35 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।